Novo Nordisk extends curbs on Wegovy

Novo Nordisk will continue to restrict US supplies of starter doses of its hugely popular Wegovy weight-loss drug in the coming quarters, as the company struggles to keep up with soaring demand.

#News #Reuters #newsfeed #weightloss #health #pharma #novonordisk

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.